Saamya Biotech (India) Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported net sales of INR 133.6 million, profit from operations before other income, interest and exceptional items of INR 4.9 million, profit from ordinary activities before tax of INR 4.9 million and net profit of INR 4.3 million or INR 0.17 per diluted share compared to loss from operations before other income, interest and exceptional items of INR 2.5 million, loss from ordinary activities before tax of INR 2.4 million and net loss of INR 2.3 million or INR 0.09 per diluted share reported in the same period last year.

For the year, the company reported net sales of INR 133.6 million, profit from operations before other income, interest and exceptional items of INR 1.65 million, profit from ordinary activities before tax of INR 1.5 million and net profit of INR 1 million or INR 0.04 per diluted share compared to loss from operations before other income, interest and exceptional items of INR 3.9 million, loss from ordinary activities before tax of INR 4.1 million and net loss of INR 4 million or INR 0.16 per diluted share reported in the same period last year.